Your shopping cart is currently empty

Silodosin-d4 is the deuterated form of Silodosin. Silodosin (KAD 3213; KMD 3213) is a potent, selective, orally active α1A-adrenergic receptor (α1A-AR) antagonist. It exhibits high affinity for α1A-AR with a Ki of 0.036 nM, which is 162 and 50 times stronger compared to its affinities for α1B-AR and α1D-AR, with Ki values of 21 nM and 2.0 nM, respectively. Silodosin is an effective and well-tolerated agent used in the research of LUTS/BPH.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Silodosin-d4 is the deuterated form of Silodosin. Silodosin (KAD 3213; KMD 3213) is a potent, selective, orally active α1A-adrenergic receptor (α1A-AR) antagonist. It exhibits high affinity for α1A-AR with a Ki of 0.036 nM, which is 162 and 50 times stronger compared to its affinities for α1B-AR and α1D-AR, with Ki values of 21 nM and 2.0 nM, respectively. Silodosin is an effective and well-tolerated agent used in the research of LUTS/BPH. |
| Molecular Weight | 499.56 |
| Formula | C25H32F3N3O4 |
| Cas No. | 1426173-86-5 |
| Smiles | C(CCO)N1C=2C(=CC(C[C@H](NC(C(OC3=C(OCC(F)(F)F)C=CC=C3)([2H])[2H])([2H])[2H])C)=CC2C(N)=O)CC1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.